TP53 and myeloproliferative disorder: TP53 loss by point mutations or chromosomal abnormalities such as gain of 1q that results in the amplification of MDM4, a p53 negative regulator, or deletion of 17p accounts for up to 50% of MPN cases evolving to sAML [19,25,83,92,93,103].